Vonoprazan Fumarate is a potassium-competitive acid blocker used to treat gastroesophageal reflux disease, peptic ulcer disease, and as part of combination therapy to eradicate Helicobacter pylori. This… Read more





Vonoprazan Fumarate is a potassium-competitive acid blocker used to treat gastroesophageal reflux disease, peptic ulcer disease, and as part of combination therapy to eradicate Helicobacter pylori. This category contains high-quality reference standards of Vonoprazan Fumarate, including its pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and quality control. By using chemically pure reference standards and isotopically labelled internal standards, researchers can achieve accurate bioanalytical quantification and reliable detection of impurities during stability testing. The availability of these standards supports the development and regulatory compliance of drug products, ensuring that analytical methods effectively monitor the drug's safety and efficacy throughout the manufacturing process.